Gabapentin in the treatment of antipsychotic-induced akathisia in schizophrenia

International Clinical Psychopharmacology

Volumn 20, Issue 3, 2005, Pages 179-181

  Pfeffer, Gerald ^a   Chouinard, Guy ^b,c,d   Margolese, Howard C ^b,c,e  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^e Allan Memorial Institute   (Canada)

Author keywords

Akathisia; Antiparkinsonian medication; Antipsychotic; Extrapyramidal symptoms; Gabapentin; Parkinsonism; Restless legs syndrome; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; DIPHENHYDRAMINE; GABAPENTIN; NEUROLEPTIC AGENT; OLANZAPINE; SEROTONIN 1D AGONIST; SEROTONIN 2 ANTAGONIST;

ADULT; AKATHISIA; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; INSOMNIA; MALE; MENTAL DISEASE; NEUROTRANSMISSION; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RESTLESS LEGS SYNDROME; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; AKATHISIA, DRUG-INDUCED; AMINES; ANTIPSYCHOTIC AGENTS; CHOLINERGIC ANTAGONISTS; CYCLOHEXANECARBOXYLIC ACIDS; DIAZEPAM; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MUSCLE RELAXANTS, CENTRAL; SCHIZOPHRENIA, PARANOID;

EID: 17644399439     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200505000-00011     Document Type: Article

References (26)

1. Adler L, Angrist B, Peselow E, Corwin J, Rotrosen J (1987). Noradrenergic mechanisms in akathisia: treatment with propranolol and clonidine. Psychopharmacol Bull 23:21-25.
2. Bhanji NH, Chouinard G, Margolese HC (2004). A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia. Eur Neuropsychopharmacol 14:87-92.
3. Brune M, Sachdev PS (2002). Ladislav Haskovec and 100 years of akathisia. Am J Psychiatry 159:727.
4. Chouinard G, Ross-Chouinard A, Annable L, Jones B (1980). The extrapyramidal symptom rating scale. Can J Neurol Sci 7:233.
5. Chouinard G, Beauclair L, Belanger MC (1998). Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders. Can J Psychiatry 43:305.
6. Chouinard G, Margolese HC, Alphs L, Larach-Walters V, Beauclair L, Anand R (2002). Relationship between baseline extrapyramidal Symptoms and suicidality in schizophrenic subjects included in the InterSePT trial. Biol Psychiatry 51:20S-21S.
7. Chouinard G, Bhanji NH, Light M, Margolese HC (2003). Patient characteristics, symptom severity, and movement disorders in patients with schizophrenia and schizoaffective disorder. Biol Psychiatry 53:21 S.
8. Duncan EJ, Adler LA, Stephanides M, Sanfilipo M, Angrist B (2000). Akathisia and exacerbation of psychopathology: a preliminary report. Clin Neuropharmacol 23:169-173.
9. Fischel T, Hermesh H, Aizenberg D, Zemishlany Z, Munitz H, Benjamini Y, et al. (2001). Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study. J Clin Psychopharmacol 21:612-615.
10. Garcia-Borreguero D, Larrosa O, de la LY. Verger K, Masramon X, Hernandez G (2002). Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 59:1573-1579.
11. 1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study. Int Clin Psychopharmacol 20:23-25.
12. Hsin-Tung E, Simpson GM (2000). Medication induced movement disorders. In: Sadock BJ, Sadock VA (editors): Kaplan and Sadock's Comprehensive Text Book of Psychiatry. Baltimore, Maryland: Williams and Wilkins, pp. 2265-2271.
13. Inada T, Beasley CM Jr, Tanaka Y, Walker DJ (2003). Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol. Int Clin Psychopharmacol 18:39-48.
14. Lima AR, Soares-Weiser K, Bacaltchuk J, Barnes TR (2002). Benzodiazepines for neuroleptic-induced acute akathisia. Cochrane Database Syst Rev CD001950.
15. Lipinski JF Jr, Zubenko GS, Cohen BM, Barreira PJ (1984). Propranolol in the treatment of neuroleptic-induced akathisia. Am J Psychiatry 141: 412-415.
16. Maneuf YP, Gonzalez MI, Sutton KS, Chung FZ, Pinnock RD, Lee K (2003). Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cell Mol Life Sci 60:742-750.
17. Margolese HC, Chouinard G, Walters-Larach V, Beauclair L (2001). Relationship between antipsychotic-induced akathisia and tardive dyskinesia and suicidality in schizophrenia: impact of clozapine and olanzapine. Acta Psychiat Belg 101:128-144.
18. Meyer JM, Simpson GM (2000). Anticholinergics and amantadine. In: Sadock BJ, Sadock VA (editors): Kaplan & Sadock's Comprehensive Textbook of Psychiatry, vol. 1 and 2. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins, pp. 2276-2282.
19. Minagar A, Kelley RE (2004). Movement disorders. Prim Care 31:111-127.
20. Olson WL, Gruenthal M, Mueller ME, Olson WH (1997). Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial. Am J Med 102:60-66.
21. Pande AC, Davidson JR, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, et al. (1999). Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 19:341-348.
22. Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, Lydiard RB, et al. (2000). Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 20:467-471.
23. Pugsley TA, Whetzel SZ, Dooley DJ (1998). Reduction of 3,4-diaminopyridine-induced biogenic amine synthesis and release in rat brain by gabapentin. Psychopharmacology (Berl) 137:74-80.
24. Sachdev PS, Brune M (2000). Animal models of acute drug-induced akathisia - a review. Neurosci Biobehav Rev 24:269-277.
25. Van Putten T, May RP (1978). 'Akinetic depression' in schizophrenia. Arch Gen Psychiatry 35:1101-1107.
26. Vinson DR, Drotts DL (2001). Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. Ann Emerg Med 37:125-131.